Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis

BMC Neurology

Volumn 13, Issue , 2013, Pages 1-9

  Saini, Harleen ^a   Rifkin, Robert ^a   Gorelik, Michael ^a   Huang, Hwa ^a,b   Ferguson, Zachary ^a,b   Jones, Melina V ^a   Levy, Michael ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Aquaporin 4; Astrocytes; Experimental autoimmune encephalomyelitis; Neuromyelitis optica; NMO IgG

Indexed keywords

IMMUNOGLOBULIN G; AQUAPORIN 4; LEUKOCYTE ANTIGEN; LY ANTIGEN; LY6G ANTIGEN, MOUSE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35 55); MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEMYELINATION; DISEASE EXACERBATION; FEMALE; HUMAN; MOUSE; MYELOOPTIC NEUROPATHY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTIC NERVE; OUTCOME ASSESSMENT; SPINAL CORD; ANIMAL; BLOOD; C57BL MOUSE; DEMYELINATING DISEASE; DISEASE MODEL; IMMUNOLOGY; METABOLISM; MYELIN SHEATH; PATHOLOGY; TIME;

ANIMALS; ANTIGENS, CD; ANTIGENS, LY; AQUAPORIN 4; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MYELIN SHEATH; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROMYELITIS OPTICA; OPTIC NERVE; PEPTIDE FRAGMENTS; SPINAL CORD; TIME FACTORS;

EID: 84882641695     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-104     Document Type: Article

References (17)

1. Graber DJ, Levy M, Kerr D, Wade WF. Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation 2008, 5:22. 10.1186/1742-2094-5-22, 2427020, 18510734.
2. McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ, Lucchinetti CF, Weinshenker BG, Wingerchuk DM, Shuster EA, Pittock SJ. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol 2009, 66:1134-1138. 10.1001/archneurol.2009.178, 19752303.
3. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130:1194-1205. 10.1093/brain/awl371, 17282996.
4. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461. 10.1093/brain/awf151, 12076996.
5. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009, 66:630-643. 10.1002/ana.21837, 19937948.
6. Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun 2009, 386:623-627. 10.1016/j.bbrc.2009.06.085, 19545538.
7. Swanborg RH. Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol Rev 2001, 184:129-135. 10.1034/j.1600-065x.2001.1840112.x, 12086308.
8. Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 2010, 6:383-392. 10.1038/nrneurol.2010.72, 20639914.
9. Jones MV, Nguyen TT, Deboy CA, Griffin JW, Whartenby KA, Kerr DA, Calabresi PA. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. J Neuroimmunol 2008, 199:83-93. 10.1016/j.jneuroim.2008.05.013, 18582952.
10. Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol 2009, 66:1164-1167. 10.1001/archneurol.2009.188, 19752309.
11. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007, 130:1235-1243. 10.1093/brain/awm062, 17449477.
12. Cayrol R, Saikali P, Vincent T. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica. Ann N Y Acad Sci 2009, 1173:478-486. 10.1111/j.1749-6632.2009.04871.x, 19758189.
13. Frohman EM, Kerr D. Is neuromyelitis optica distinct from multiple sclerosis?: something for " lumpers" and " splitters" Arch Neurol 2007, 64:903-905. 10.1001/archneur.64.6.903, 17562944.
14. Weinstock-Guttman B, Miller C, Yeh E, Stosic M, Umhauer M, Batra N, Munschauer F, Zivadinov R, Ramanathan M. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica. Mult Scler 2008, 14(8):1061-1067. 10.1177/1352458508092811, 18573816.
15. Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S. Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. Biochem Biophys Res Commun 2010, 394:205-210. 10.1016/j.bbrc.2010.02.157, 20188706.
16. Lapointe BM, Herx LM, Gill V, Metz LM, Kubes P. IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment. Brain 2004, 127:2649-2656. 10.1093/brain/awh297, 15355874.
17. Tani T, Sakimura K, Tsujita M, Nakada T, Tanaka M, Nishizawa M, Tanaka K. Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica. J Neuroimmunol 2009, 211:110-113. 10.1016/j.jneuroim.2009.04.001, 19410301.